RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial

Journal of the National Cancer Institute

Volumn 106, Issue 4, 2014, Pages

  Tokudome, Shinkan ^a,b   Ando, Ryosuke ^b   Ichikawa, Yuko ^c,d   Ichikawa, Hiromitsu ^b   Imaeda, Nahomi ^e   Goto, Chiho ^f   Tokudome, Yuko ^g   Okuyama, Harumi ^d  

^a NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c NGO Council for the Safety Evaluation of Fats and Oils in Foods   (Japan)

^d KINJO GAKUIN UNIVERSITY   (Japan)

^e NAGOYA WOMEN'S UNIVERSITY   (Japan)

^f NAGOYA BUNRI UNIVERSITY   (Japan)

^g NAGOYA UNIVERSITY OF ARTS AND SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

BLOOD; HUMAN; MALE; NOTE; PROSTATE TUMOR;

FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 84898861760     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju020     Document Type: Letter

References (4)

1. Brasky TM, Dake AM, Song X, et al. Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. J Natl Cancer Inst. 2013;105(15):1132-1141
2. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: American Institute for Cancer Research; 2007.
3. Thun MJ, Henley SJ, Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst. 2002;94(4):252-266.
4. Okuyama H. High n-6 to n-3 ratio of dietary fatty acids rather than serum cholesterol as a major risk factors for coronary heart disease. Eur J Lipid SciTechnol. 2001;103:418-422.